Arizona State Retirement System Bristol Myers Squibb CO Transaction History

Arizona State Retirement System

  • $14.3 Billion
  • Q1 2024

A detailed history of Arizona State Retirement System transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Arizona State Retirement System holds 583,908 shares of BMY stock, worth $24.2 Million. This represents 0.22% of its overall portfolio holdings.

Number of Shares
583,908
Previous 587,757 0.65%
Holding current value
$24.2 Million
Previous $30.2 Million 5.0%
% of portfolio
0.22%
Previous 0.23%

Shares

27 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 07, 2024
SELL
$47.98 - $54.4 $184,675 - $209,385
-3,849 Reduced 0.65%
583,908 $31.7 Million
Q4 2023

Jan 24, 2024
SELL
$48.48 - $57.85 $334,172 - $398,760
-6,893 Reduced 1.16%
587,757 $30.2 Million
Q3 2023

Nov 06, 2023
SELL
$57.89 - $64.73 $380,337 - $425,276
-6,570 Reduced 1.09%
594,650 $34.5 Million
Q2 2023

Aug 01, 2023
BUY
$63.71 - $70.74 $1.32 Million - $1.46 Million
20,687 Added 3.56%
601,220 $38.4 Million
Q1 2023

Apr 27, 2023
SELL
$65.71 - $74.53 $82,991 - $94,131
-1,263 Reduced 0.22%
580,533 $40.2 Million
Q4 2022

Feb 07, 2023
BUY
$68.48 - $81.09 $209,617 - $248,216
3,061 Added 0.53%
581,796 $41.9 Million
Q3 2022

Nov 07, 2022
SELL
$0.13 - $76.84 $2,503 - $1.48 Million
-19,260 Reduced 3.22%
578,735 $41.1 Million
Q2 2022

Jul 28, 2022
SELL
$72.62 - $79.98 $804,121 - $885,618
-11,073 Reduced 1.82%
597,995 $46 Million
Q1 2022

May 04, 2022
BUY
$61.48 - $73.72 $29,203 - $35,017
475 Added 0.08%
609,068 $44.5 Million
Q4 2021

Feb 04, 2022
SELL
$53.63 - $62.52 $770,341 - $898,037
-14,364 Reduced 2.31%
608,593 $37.9 Million
Q3 2021

Nov 12, 2021
SELL
$59.17 - $69.31 $282,181 - $330,539
-4,769 Reduced 0.76%
622,957 $36.9 Million
Q2 2021

Aug 02, 2021
SELL
$61.91 - $67.42 $562,204 - $612,241
-9,081 Reduced 1.43%
627,726 $41.9 Million
Q1 2021

May 06, 2021
SELL
$59.34 - $66.74 $801,505 - $901,457
-13,507 Reduced 2.08%
636,807 $40.2 Million
Q4 2020

Jan 28, 2021
SELL
$57.74 - $65.43 $2.18 Million - $2.47 Million
-37,819 Reduced 5.5%
650,314 $40.3 Million
Q3 2020

Nov 05, 2020
BUY
$57.43 - $63.64 $9.06 Million - $10 Million
157,829 Added 29.76%
688,133 $41.5 Million
Q2 2020

Aug 04, 2020
BUY
$54.82 - $64.09 $3.42 Million - $4 Million
62,380 Added 13.33%
530,304 $31.2 Million
Q1 2020

May 05, 2020
SELL
$46.4 - $67.43 $752,097 - $1.09 Million
-16,209 Reduced 3.35%
467,924 $26.1 Million
Q4 2019

Jan 27, 2020
BUY
$49.21 - $64.19 $6.61 Million - $8.62 Million
134,266 Added 38.38%
484,133 $31.1 Million
Q3 2019

Oct 31, 2019
SELL
$42.77 - $50.71 $286,687 - $339,909
-6,703 Reduced 1.88%
349,867 $17.7 Million
Q2 2019

Jul 25, 2019
BUY
$44.62 - $49.34 $1.92 Million - $2.12 Million
43,067 Added 13.74%
356,570 $16.2 Million
Q1 2019

Apr 29, 2019
SELL
$45.12 - $53.8 $986,142 - $1.18 Million
-21,856 Reduced 6.52%
313,503 $15 Million
Q4 2018

Jan 28, 2019
SELL
$48.76 - $63.23 $3.37 Million - $4.37 Million
-69,109 Reduced 17.09%
335,359 $17.4 Million
Q3 2018

Oct 29, 2018
BUY
$55.19 - $62.25 $162,479 - $183,264
2,944 Added 0.73%
404,468 $25.1 Million
Q2 2018

Aug 07, 2018
SELL
$50.53 - $62.98 $179,634 - $223,893
-3,555 Reduced 0.88%
401,524 $22.2 Million
Q1 2018

May 14, 2018
SELL
$59.92 - $68.98 $575,232 - $662,208
-9,600 Reduced 2.32%
405,079 $25.6 Million
Q4 2017

Feb 09, 2018
BUY
$59.94 - $65.35 $490,069 - $534,301
8,176 Added 2.01%
414,679 $25.4 Million
Q3 2017

Nov 14, 2017
BUY
$55.23 - $63.74 $22.5 Million - $25.9 Million
406,503
406,503 $25.9 Million

Others Institutions Holding BMY

# of Institutions
2,554
Shares Held
1.49B
Call Options Held
25.9M
Put Options Held
20M
View Full List

About BRISTOL MYERS SQUIBB CO

BMY Quotes by TradingView
  • Ticker BMY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,126,160,000
  • Market Cap $88.3B
  • Description
  • Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...
More about BMY
Track This Portfolio

Track Arizona State Retirement System Portfolio

Follow Arizona State Retirement System and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Arizona State Retirement System, based on Form 13F filings with the SEC.

News

Stay updated on Arizona State Retirement System with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email